178 related articles for article (PubMed ID: 10744046)
41. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.
Wyskida K; Żak-Gołąb A; Wajda J; Klein D; Witkowicz J; Ficek R; Rotkegel S; Spiechowicz U; Kocemba Dyczek J; Ciepał J; Olszanecka-Glinianowicz M; Więcek A; Chudek J
Int Urol Nephrol; 2016 May; 48(5):765-71. PubMed ID: 27000106
[TBL] [Abstract][Full Text] [Related]
42. Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma.
Hong YM; Cho M; Yoon KT; Chu CW; Yang KH; Park YM; Rhu JH
Tumour Biol; 2017 Oct; 39(10):1010428317720863. PubMed ID: 29034775
[TBL] [Abstract][Full Text] [Related]
43. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
[TBL] [Abstract][Full Text] [Related]
44. [The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein].
Sakon M; Monden M; Goto M; Kanai T; Umeshita K; Endo W; Mori T
Nihon Geka Gakkai Zasshi; 1990 May; 91(5):588-93. PubMed ID: 1696680
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical studies of PIVKA-II in hepatocellular carcinoma by indirect immunofluorescence.
Kuwahara N; Higashi T; Nouso K; Ito T; Tsuji T
Acta Med Okayama; 1995 Feb; 49(1):19-24. PubMed ID: 7762405
[TBL] [Abstract][Full Text] [Related]
46. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
[TBL] [Abstract][Full Text] [Related]
47. Hepatic concentration of vitamin K active compounds after application of phylloquinone to chickens on a vitamin K deficient or adequate diet.
Guillaumont M; Weiser H; Sann L; Vignal B; Leclercq M; Frederich A
Int J Vitam Nutr Res; 1992; 62(1):15-20. PubMed ID: 1587702
[TBL] [Abstract][Full Text] [Related]
48. Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats.
Yamamoto R; Komai M; Kojima K; Furukawa Y; Kimura S
J Nutr Sci Vitaminol (Tokyo); 1997 Feb; 43(1):133-43. PubMed ID: 9151247
[TBL] [Abstract][Full Text] [Related]
49. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
50. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
51. Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Minakuchi K; Murata K; Kaminoh T; Takada K; Takashima S; Nakamura K; Onoyama Y
Radiat Med; 1993; 11(6):231-6. PubMed ID: 7512271
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
53. PIVKA-II during perioperative period in patients with hepato-biliary-pancreatic diseases.
Kanazumi N; Takeda S; Inoue S; Ohshima K; Sugimoto H; Kaneko T; Watanabe K; Nakao A
Hepatogastroenterology; 2000; 47(36):1695-9. PubMed ID: 11149034
[TBL] [Abstract][Full Text] [Related]
54. Interaction between vitamin K nutriture and bacterial overgrowth in hypochlorhydria induced by omeprazole.
Paiva SA; Sepe TE; Booth SL; Camilo ME; O'Brien ME; Davidson KW; Sadowski JA; Russell RM
Am J Clin Nutr; 1998 Sep; 68(3):699-704. PubMed ID: 9734750
[TBL] [Abstract][Full Text] [Related]
55. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat.
Ronden JE; Drittij-Reijnders MJ; Vermeer C; Thijssen HH
Biochim Biophys Acta; 1998 Jan; 1379(1):69-75. PubMed ID: 9468334
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
57. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
Bertino G; Ardiri AM; Boemi PM; Ierna D; Interlandi D; Caruso L; Minona E; Trovato MA; Vicari S; Li Destri G; Puleo S
Panminerva Med; 2008 Sep; 50(3):221-6. PubMed ID: 18927526
[TBL] [Abstract][Full Text] [Related]
58. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
[TBL] [Abstract][Full Text] [Related]
59. The growth inhibitory effects of vitamins K and their actions on gene expression.
Wang Z; Wang M; Finn F; Carr BI
Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
[TBL] [Abstract][Full Text] [Related]
60. Mediastinal Yolk Sac Tumor Producing Protein Induced by Vitamin K Absence or Antagonist-II.
Akutsu N; Adachi Y; Isosaka M; Mita H; Takagi H; Sasaki S; Yamamoto H; Arimura Y; Ishii Y; Masumori N; Endo T; Shinomura Y
Intern Med; 2015; 54(12):1531-6. PubMed ID: 26073245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
